End Of Exanta: AstraZeneca Drops Drug After New Report Of Liver Injury
This article was originally published in The Pink Sheet Daily
Executive Summary
The firm is pulling its U.S. application for the anticoagulant and will remove the drug from European markets following a report of serious liver injury.